Dermata Therapeutics, Inc. (DRMA)
NASDAQ: DRMA · Real-Time Price · USD
1.137
-0.043 (-3.64%)
Nov 22, 2024, 4:00 PM EST - Market closed

Dermata Therapeutics Balance Sheet

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
TTM FY 2023 FY 2022 FY 2021 FY 2020 FY 2019
Period Ending
Sep '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '19
Cash & Equivalents
6.147.446.2410.80.531.99
Cash & Short-Term Investments
6.147.446.2410.80.531.99
Cash Growth
-7.35%19.18%-42.20%1935.97%-73.37%-
Other Receivables
-0.010.01---
Receivables
-0.010.01---
Prepaid Expenses
0.540.440.60.770.080.07
Other Current Assets
-0.090.090.06--
Total Current Assets
6.697.986.9411.620.612.07
Property, Plant & Equipment
-----0
Total Assets
6.697.986.9411.620.612.07
Accounts Payable
0.860.870.50.520.10.34
Accrued Expenses
1.080.760.4310.130.16
Short-Term Debt
----2.99-
Current Portion of Long-Term Debt
----0.560.73
Other Current Liabilities
-----0.5
Total Current Liabilities
1.951.620.921.523.781.72
Long-Term Debt
-----0.55
Total Liabilities
1.951.620.921.523.782.28
Common Stock
00002.352.35
Additional Paid-In Capital
67.2759.7451.6146.09--
Retained Earnings
-62.52-53.39-45.59-35.98-28.08-24.84
Total Common Equity
4.746.366.0210.11-25.73-22.49
Shareholders' Equity
4.746.366.0210.11-3.18-0.21
Total Liabilities & Equity
6.697.986.9411.620.612.07
Total Debt
----3.551.28
Net Cash (Debt)
6.147.446.2410.8-3.020.71
Net Cash Growth
-7.35%19.18%-42.20%---
Net Cash Per Share
8.1938.15135.55602.41--
Filing Date Shares Outstanding
2.040.440.050.0346.66-
Total Common Shares Outstanding
1.680.260.050.0346.66-
Working Capital
4.746.366.0210.11-3.180.34
Book Value Per Share
2.8324.25117.29291.25-0.55-
Tangible Book Value
4.746.366.0210.11-25.73-22.49
Tangible Book Value Per Share
2.8324.25117.29291.25-0.55-
Machinery
-----0.08
Source: S&P Capital IQ. Standard template. Financial Sources.